SL Moulder
Impact in
- Oncology top 5%
- Cancer Immunotherapy and Biomarkers
- HER2/EGFR in Cancer Research
- CAR-T cell therapy research
- Cancer Research top 10%
- Cancer Genomics and Diagnostics
Papers in
- Oncology 12
- Cancer Treatment and Pharmacology 7
- Cancer-related Molecular Pathways 3
- HER2/EGFR in Cancer Research 3
- Peptidase Inhibition and Analysis 2
- Cancer Diagnosis and Treatment 2
-
- Advanced Breast Cancer Therapies 7
- Brain Metastases and Treatment 2
- Co-authors
- Marleen Kok (1 shared paper)Renata Ferrarotto (1 shared paper)Eric Jonasch (1 shared paper)S.-Y. Lin (1 shared paper)Leonie Voorwerk (1 shared paper)Bora Lim (2 shared papers)Daniel J. McGrail (1 shared paper)Maarten Slagter (1 shared paper)
- Journals
- Cancer Research (10 papers)Journal of Clinical Oncology (3 papers)Annals of Oncology (3 papers)
- Partner nations
- United StatesCanadaSwitzerland
In The Last Decade
SL Moulder
15 papers receiving 847 citations
SL Moulder's Hit Papers
Peers
Comparison fields: 5 of 52
- Oncology 509
- Cancer Research 178
- Pulmonary and Respiratory Medicine 262
- Immunology 166
- Genetics 50
Countries citing papers authored by SL Moulder
This map shows the geographic impact of SL Moulder's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by SL Moulder with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites SL Moulder more than expected).
Fields of papers citing papers by SL Moulder
This network shows the impact of papers produced by SL Moulder. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by SL Moulder. The network helps show where SL Moulder may publish in the future.
Co-authors
The 25 scholars most cited alongside SL Moulder, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | High tumor mutation burden fails to predict immune checkpoint blockade response across all cancer types Hit paper breakdown → | 2021 | 705 |
| 2 | 2016 | 47 | |
| 3 | 2013 | 26 | |
| 4 | 2007 | 20 | |
| 5 | 2010 | 11 | |
| 6 | 2007 | 9 | |
| 7 | 2017 | 7 | |
| 8 | 2008 | 7 | |
| 9 | 2016 | 6 | |
| 10 | 2010 | 4 | |
| 11 | 2016 | 3 | |
| 12 | 2017 | 2 | |
| 13 | 2017 | 1 | |
| 14 | 2019 | 1 | |
| 15 | 2017 | 1 | |
| 16 | 2018 | 0 |
About SL Moulder
SL Moulder is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Cancer Research, Radiology, Nuclear Medicine and Imaging and Genetics, having authored 16 papers that have together received 850 indexed citations. Recurring topics across this work include Cancer Treatment and Pharmacology (7 papers), Advanced Breast Cancer Therapies (7 papers), Cancer-related Molecular Pathways (3 papers), HER2/EGFR in Cancer Research (3 papers), Cancer Genomics and Diagnostics (2 papers), Peptidase Inhibition and Analysis (2 papers), Brain Metastases and Treatment (2 papers) and Cancer Diagnosis and Treatment (2 papers). The work is most often cited by research in Oncology (509 citations), Cancer Research (178 citations), Pulmonary and Respiratory Medicine (262 citations), Immunology (166 citations) and Genetics (50 citations). SL Moulder has collaborated with scholars based in United States, Canada and Switzerland. Frequent co-authors include Marleen Kok, Renata Ferrarotto, Eric Jonasch, S.-Y. Lin, Leonie Voorwerk, Bora Lim, Daniel J. McGrail, Maarten Slagter, Naoto T. Ueno and JK Litton. Their work appears in journals such as Cancer Research, Journal of Clinical Oncology and Annals of Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.